IKT · Inhibikase Therapeutics, Inc. · Debt
$1.53
-0.10 (-6.13%)
At close · Nov 12
Return incl. dividend (before tax)
Q2 2024 earnings call transcript
Market Cap
$214.61M
Shares
140.27M
Volume · Nov 12
728.31K
Avg daily vol (3M)
566.38K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Read debt and covenant terms in your AI or your code through MCP and the API →Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current long-term debt and lease obligations | 2025-12-31 | USD 0 | 10-K filed 2026-03-26 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1750149
CUSIP
45719W205
13F (30d)
48 filings
45 filers
Visit website
Investor relations